New York, NY – September 26, 2025 – The financial markets today greeted the August 2025 Personal Consumption Expenditures (PCE) inflation report with a resounding cheer, sending the Dow Jones Industrial Average (DJIA) (NYSE: ^DJI) soaring by approximately 300 points. Despite year-over-year headline inflation showing a slight acceleration, the report's "in-line" nature—
Shares of vocational education Universal Technical Institute (NYSE:UTI)
jumped 3.4% in the afternoon session after the stock extended its positive momentum as Truist Securities reiterated its Buy rating and $40 price target on the stock.
Shares of e-commerce pet food and supplies retailer Chewy (NYSE:CHWY) jumped 3.9% in the afternoon session after the stock's positive momentum continued as MoffettNathanson upgraded the company to a "Buy" rating and set a price target of $48.
Shares of footwear company Crocs (NASDAQ:CROX)
jumped 4.4% in the afternoon session after the company launched a new advertising campaign for its HeyDude brand featuring actress Sydney Sweeney, supported by broader market optimism as economic reports showed consumer spending rose more than expected.
The global food system is at a critical juncture, facing the dual pressures of feeding a growing population and mitigating the escalating impacts of climate change. Against this backdrop, "climate-smart food" initiatives are rapidly emerging as a transformative force, fundamentally reshaping the landscape of agricultural commodity markets. These initiatives, driven
Shares of infrastructure and agriculture equipment manufacturer Valmont Industries (NYSE:VMI)
jumped 4.1% in the morning session after J.P. Morgan initiated coverage on the company with an "Overweight" rating and a $480 price target.
Shares of recreational vehicle (RV) and boat retailer Camping World (NYSE:CWH)
jumped 2% in the morning session after Citigroup maintained its "Buy" rating and increased its price target on the stock. The firm's analyst, James Hardiman, lifted the price target from $21.00 to $22.00, an increase of 4.76%. This adjustment reflected a positive sentiment towards the company's potential and signaled a confident outlook for the recreational vehicle retailer's shares.
Shares of pest control company Rollins (NYSE:ROL)
jumped 2.7% in the morning session after JPMorgan initiated coverage on the pest control company with an "Overweight" rating and a $70 price target.
Shares of trucking company PACCAR (NASDAQ:PCAR)
jumped 4.9% in the morning session after the U.S. administration announced it would impose a 25% tariff on imported heavy-duty trucks.
The Dow Jones Industrial Average (DJIA) has successfully halted a three-session losing streak, with U.S. stock futures indicating a positive opening on Friday, September 26, 2025. This much-anticipated rebound comes as investors digest a crucial U.S. inflation reading, the Personal Consumption Expenditures (PCE) index, which aligned with market
New York, NY – September 26, 2025 – The financial markets today reacted with cautious optimism as the Personal Consumption Expenditures (PCE) inflation data for August 2025 largely met Wall Street's expectations. This crucial economic indicator, the Federal Reserve's preferred gauge of inflation, provided a degree of reassurance to investors, leading to
As September 25, 2025, dawns, a palpable tension hangs over the financial markets. Whispers of an "AI bubble" have grown into a chorus of concern, driving a noticeable shift in investor sentiment. Fuelled by exorbitant valuations, disappointing returns on massive AI investments, and a growing sense of déjà vu reminiscent
As the financial world braces for a series of pivotal inflation data releases in late 2025, market participants are on high alert. These forthcoming reports, including the Consumer Price Index (CPI) and the Personal Consumption Expenditures (PCE) price index, are not merely statistical updates; they represent a critical juncture that
The U.S. labor market showed significant signs of cooling in August 2025, with job growth falling well below expectations and the unemployment rate ticking upward. This shift has prompted a decisive response from the Federal Reserve, which, at its September 2025 meeting, enacted its first interest rate cut since
Shares of biotech company Regeneron (NASDAQ:REGN)
fell 4.1% in the afternoon session after the company highlighted challenges, including regulatory approvals and competitive pressures, at a healthcare forum.
Shares of self defense company AXON (NASDAQ:AXON)
jumped 2.9% in the afternoon session after it announced a deal to acquire Prepared, an AI-powered emergency communications company.
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY)
fell 3.1% in the afternoon session after the company halted a mid-stage clinical trial for its experimental drug, bimagrumab, which was intended to prevent muscle loss in patients taking its blockbuster obesity treatment, Zepbound.
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs.
Shares of healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC)
fell 4.3% in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs.
Shares of healthcare solutions company Evolent Health (NYSE:EVH)
fell 3.4% in the morning session after investment firm Stephens reiterated its 'equal weight' rating on the company. The firm maintained its $9.00 price target on the technology company's stock. An 'equal weight' rating suggests the analyst, Jeff Garro, did not foresee any significant short-term change in the company's stock performance. This reinforcement of a neutral stance may have disappointed investors who were looking for a more positive outlook, contributing to the stock's decline.
Shares of diagnostics company Guardant Health (NASDAQ:GH)
jumped 5.2% in the morning session after the company announced a collaboration with Quest Diagnostics and provided an upbeat financial outlook at its investor day. The partnership aimed to make Guardant's Shield blood-based cancer screening test more widely available to physicians and patients in the United States. During its investor event, the company also revealed it accelerated its timeline for reaching cash flow breakeven by about 12 months.
